ArticleRadiology case reports2026
Late-occurring inflammatory process mimicking tumor recurrence following cryoablation for renal cell carcinoma: A case series.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Local tumor progression (LTP) is one of the concerning complications after cryoablation therapy for patients with early-stage renal cell carcinoma (RCC). Imaging findings of tumor recurrence following cryoablation for RCC typically include residual contrast enhancement or enlargement of the non-enhancing ablation zone. However, late-onset inflammatory changes-though rare-can mimic tumor recurrence. We present 3 cases, 74-year-old male, 86-year-old male and 70-year-old male, with RCC following cryoablation with initially suggested tumor recurrence, but later pathology proved to be late-onset inflammation. The key imaging feature is new peripheral enhancing soft tissue at the margin of the ablation zone, appearing at a mean interval of 84 months post-cryoablation-substantially later than the typical timeframe for Local tumor progression (LTP). All patients had well-controlled type 2 diabetes mellitus. Thus, in patients with a remote history of RCC cryoablation, peripheral enhancement at the ablation margin-rather than within the ablated tumor-on long-term follow-up may represent a late-onset inflammatory process rather than true recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.